There is a research finding that ISL alleviated NAFLD through modulating miR-138-5p/PGC-1α-mediated lipid metabolism and inflammatory reaction in vivo and in vitro (Wang et al., 2022b). This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatotic liver disease.